Latest news – Page 163
-
NewsFirst-in-human vaccine trial for deadly Nipah virus launched
The University of Oxford has launched a new clinical trial to test a vaccine to protect people against deadly Nipah virus. The first clinical trial participants received doses of the ChAdOx1 NipahB vaccine over the last week.
-
NewsGlow sticks deployed to ID emerging biothreats
Glow sticks are being used by a University of Houston researcher to identify emerging biothreats for the United States Navy.
-
NewsResearch lays groundwork for a lifesaving vaccine for bacterium that threatens newborns
Researchers are unraveling the workings of Streptococcus agalactiae infections, which could someday lead to a vaccine.
-
NewsPirola variant of Covid rediscovers entry pathway into lung cells
Researchers have discovered that the Pirola variant enters lung cells with high efficiency and uses the cellular enzyme TMPRSS2 for entry, thereby exhibiting parallels to variants Alpha, Beta, Gamma and Delta.
-
NewsRSV shown to infect nerve cells, causing inflammation and damage
Long thought to only infect the respiratory tract, RSV has been found to infect nerve cells, cause nerve damage and enter the spinal cord, potentially granting access to the central nervous system.
-
NewsWar on bugs can’t be won, researchers declare
A new paper calls for antimicrobial resistance to be reframed as a sustainability issue.
-
NewsNew NIH-funded center could soon reduce the need for pharmaceutical trials on animals
The University of Rochester will house a new national center focused on using tissue-on-chip technology to develop drugs more rapidly and reduce the need for animal trials.
-
NewsScientists uncover role of helper MLRs in tomato immune response to pathogen attack
An innovative study delves into the intricate defense mechanisms of tomatoes against the notorious bacterial pathogen, Pseudomonas syringae pv. tomato (Pst).
-
NewsSickle cell raises COVID-19 risk, but vaccination lags
Adults with sickle cell disease around half as likely to have had initial doses as people without sickle cell disease, a study in Michigan shows.
-
NewsPotential nasal COVID-19 vaccine candidate offers better and longer protection
Study shows that administering a COVID-19 vaccine as a nasal spray rather than a subcutaneous injection enhances the body’s long-term immune memory, thereby increasing the vaccine’s overall effectiveness.
-
NewsPhages pay heavy price for environmental intel - but it’s worth it
Phages, the viruses that infect bacteria, will pay a high growth-rate cost to access environmental information that can help them choose which lifecycle to pursue, according to a study. Source: L. F. Lee; J. A. Boezi Bacteriophage gh-1 for Pseudomonas putida. Yigal Meir and colleagues at Ben-Gurion ...
-
NewsAI platform for wastewater plants harnesses microbiome and engineering data
Scientists have introduced a groundbreaking Global WWTP Microbiome-based Integrative Information Platform to address the escalating complexities of pollutants and inadequacies in traditional wastewater treatment plants.
-
NewsValneva vaccinates first participant in pediatric trial of single-shot Chikungunya vaccine
Valneva SE has announced that the first participant has been vaccinated in the Phase 2 clinical trial evaluating the safety and immunogenicity in children of two different dose levels of Valneva’s single-shot chikungunya vaccine.
-
NewsMicroplastics affect soil fungi depending on drought conditions
Moisture levels in the soil can impact the effects that microplastic pollution has on soil fungi, according to new research published in Environmental Microbiology, an Applied Microbiology International publication.
-
NewsHigher viral load during HIV infection can shape viral evolution
A new paper finds that HIV populations in people with higher viral loads also have higher rates of viral recombination.
-
NewsPredominantly plant-based or vegetarian diet linked to 39% lower odds of COVID-19
A predominantly plant-based or vegetarian diet is linked to 39% lower odds of COVID-19 infection, finds new research.
-
NewsCrop spray could lead to mass resistance in new-generation antifungal treatments
An agricultural fungicide approved in the US and currently under consideration by authorities worldwide could have a devastating effect on a new drug for one of world’s deadliest infectious diseases.
-
NewsVaccine boosts innate immunity in people with dormant immune cells
Epigenetic cell states predict whether or not an individual profits from the “wake-up call” to the innate immune system that is provided by the BCG vaccine.
-
NewsZika virus is effective when used to treat a type of childhood cancer in mice
Injecting neuroblastoma tumors with Zika virus shrank or eliminated those tumors in studies with mice, suggesting that the virus could someday serve as an effective cancer therapy, according to a new study.
-
NewsNovo Nordisk Foundation partners with CARB-X to fight drug-resistant infections
The Novo Nordisk Foundation is committing up to $25 million to support the early-stage development of innovative tools to prevent, diagnose and treat the most dangerous drug-resistant bacterial infections. The three-year grant will go to the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), the leading global non-profit public-private partnership in this ...